After Johnson & Johnson initiated a share-exchange offer to significantly reduce its holdings in Kenvue, the company says it's keeping about a 9.5% stake in the consumer health spinoff.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,